Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 143 Myelodysplastic Syndromes 53 Leukemia 24 Leukemia, Myelomonocytic, Chronic 21 Recurrence 12 Myeloproliferative Disorders 7 Leukemia, Biphenotypic, Acute 7 Carcinoma, Non-Small-Cell Lung 7 Lymphoma, T-Cell, Peripheral 6 Leukemia, Monocytic, Acute 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm, Residual 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myelomonocytic, Acute 5 Anemia, Refractory, with Excess of Blasts 5 Neoplasms 4 Leukemia, Erythroblastic, Acute 4 Congenital Abnormalities 4 Prostatic Neoplasms 3 Primary Myelofibrosis 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma 3 Leukemia, Megakaryoblastic, Acute 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Breast Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycythemia Vera 2 Pancreatic Neoplasms 2

Interventions

Temozolomide 69 Bevacizumab 40 Radiotherapy 22 Magnetic Resonance Spectroscopy 20 Irinotecan 17 Specimen Handling 10 Carboplatin 10 Carmustine 9 X-Rays 7 Radiation 7 olaparib 6 Surgical Procedures, Operative 6 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 6 Nivolumab 6 Everolimus 6 Cyclophosphamide 6 Biopsy 6 trametinib 5 Thalidomide 5 Cisplatin 5 pembrolizumab 4 palbociclib 4 fluorodopa F 18 4 erdafitinib 4 dabrafenib 4 Lomustine 4 Etoposide 4 Drug Therapy 4 Doxorubicin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Glioma × Azacitidine × Clear all

NCT03666559 2024-02-29

AGIR

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡